Organic Dissociative Syndrome Associated with Antimigraine Pharmacotherapy
- 1 October 1991
- journal article
- case report
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 36 (8) , 597-599
- https://doi.org/10.1177/070674379103600810
Abstract
This report describes an acute organic brain syndrome with a fugue-like state in association with antimigraine pharmacotherapy. The differential diagnosis of: 1. possible psychotoxic effects of the combination of propranolol, Imipramine, and butalbital; 2. confusional migraine with amnesia; and 3. psychogenic dissociation is considered. Although organically induced dissociative states are of clinical, neuropsychological and medico-legal significance, the DSM-III and DSM-III-R have specific categories only for dissociative conditions that are strictly psychogenic in origin.Keywords
This publication has 17 references indexed in Scilit:
- Amnesia-producing drugs affect hippocampal frequency potentiationNeuroscience, 1983
- Organic brain syndrome with nadololArchives of internal medicine (1960), 1981
- Acute organic brain syndrome from nadolol therapyArchives of internal medicine (1960), 1981
- Transient Global Amnesia in MigraineHeadache: The Journal of Head and Face Pain, 1979
- Organic Brain Syndrome with PropranololNew England Journal of Medicine, 1979
- ACUTE BRAIN SYNDROME AFTER PROPRANOLOL TREATMENTThe Lancet, 1977
- The concept of drug automatismAmerican Journal of Psychiatry, 1976
- Imipramine side effects in childrenPsychopharmacology, 1974
- Confusional Episodes and Antidepressant MedicationAmerican Journal of Psychiatry, 1971
- PSYCHIC MANIFESTATIONS IN MIGRAINEAmerican Journal of Psychiatry, 1924